| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | GALENA BIOPHARMA INCORPORATED COM NEW | 46,145 | 28,000 | 0.02% | ||
| 2 | BioPharmX Corporation | 115,000 | 58,000 | 0.05% | ||
| 3 | TONIX PHARMACEUTICALS HLDG C | 20,000 | 93,000 | 0.08% | ||
| 4 | ANAPTYSBIO INC | 4,500 | 125,000 | 0.11% | ||
| 5 | ADAMIS PHARMACEUTICALS CORP | 30,000 | 128,000 | 0.11% | ||
| 6 | Pieris Pharmaceuticals | 53,525 | 139,000 | 0.12% | ||
| 7 | AFFIMED N V COM | 92,500 | 213,000 | 0.18% | ||
| 8 | AXSOME THERAPEUTICS INC COM | 55,700 | 217,000 | 0.18% | ||
| 9 | BELLICUM PHARMACEUTICALS INCORPORATED | 20,000 | 247,000 | 0.21% | ||
| 10 | ObsEva SA | 25,000 | 260,000 | 0.22% | ||
| 11 | MASIMO CORP | 3,500 | 326,000 | 0.28% | ||
| 12 | CELYAD SA | 12,528 | 328,000 | 0.28% | ||
| 13 | ABEONA THERAPEUTICS INC | 67,537 | 338,000 | 0.29% | ||
| 14 | INOTEK PHARMACEUTICALS CORP | 600,000 | 372,000 | 0.31% | PRN | |
| 15 | CYMABAY THERAPEUTICS INC | 88,067 | 379,000 | 0.32% | ||
| 16 | Sierra Oncology Inc. | 265,000 | 405,000 | 0.34% | ||
| 17 | EIGER BIOPHARMACEUTICALS INC | 35,977 | 412,000 | 0.35% | ||
| 18 | INOTEK PHARMACEUTICALS CORP | 237,135 | 474,000 | 0.40% | ||
| 19 | Ascendis Pharma | 18,214 | 510,000 | 0.43% | ||
| 20 | GEMPHIRE THERAPEUTICS INC | 52,797 | 554,000 | 0.47% | ||
| 21 | COGENTIX MED INC | 353,482 | 636,000 | 0.54% | ||
| 22 | AKEBIA THERAPEUTICS INC | 70,455 | 648,000 | 0.55% | ||
| 23 | ZOGENIX INC | 59,778 | 649,000 | 0.55% | ||
| 24 | NEOS THERAPEUTICS INC COM | 95,273 | 686,000 | 0.58% | ||
| 25 | IRONWOOD PHARMACEUTICALS INC DBCV 2.250 6/1 | 573,000 | 714,000 | 0.60% | PRN | |
| 26 | NOVADAQ TECHNOLOGIES INC | 95,841 | 747,000 | 0.63% | ||
| 27 | CASCADIAN THERAPEUTICS INC | 185,259 | 767,000 | 0.65% | ||
| 28 | Stereotaxis Inc | 1,372,862 | 782,000 | 0.66% | ||
| 29 | Exactech Inc | 31,636 | 797,000 | 0.67% | ||
| 30 | BLUEBIRD BIO INC COM | 9,000 | 818,000 | 0.69% | ||
| 31 | MINERVA NEUROSCIENCES INC COM | 101,317 | 821,000 | 0.69% | ||
| 32 | ACHILLION PHARMACEUTICALS IN | 196,500 | 827,000 | 0.70% | ||
| 33 | ArQule Inc | 807,008 | 855,000 | 0.72% | ||
| 34 | TANDEM DIABETES CARE INC COM | 724,286 | 869,000 | 0.74% | ||
| 35 | SYNERON MEDICAL LTD | 85,947 | 907,000 | 0.77% | ||
| 36 | VOYAGER THERAPEUTICS INC | 71,320 | 944,000 | 0.80% | ||
| 37 | DERMIRA INC COM | 28,000 | 955,000 | 0.81% | ||
| 38 | BIOLINERX LTD | 1,000,000 | 961,000 | 0.81% | ||
| 39 | NEURODERM LTD | 37,438 | 994,000 | 0.84% | ||
| 40 | SCYNEXIS INC | 381,900 | 1,054,000 | 0.89% | ||
| 41 | JOHNSON & JOHNSON | 9,400 | 1,171,000 | 0.99% | ||
| 42 | UNIQURE NV | 203,907 | 1,179,000 | 1.00% | ||
| 43 | XENON PHARMACEUTICALS INC | 339,614 | 1,358,000 | 1.15% | ||
| 44 | ADVAXIS INC COM NEW | 172,000 | 1,405,000 | 1.19% | ||
| 45 | RIGEL PHARMACEUTICAL INC | 473,478 | 1,567,000 | 1.33% | ||
| 46 | FOAMIX PHARMACEUTICALS LTD | 325,667 | 1,612,000 | 1.36% | ||
| 47 | CIDARA THERAPEUTICS INC | 208,458 | 1,626,000 | 1.38% | ||
| 48 | IMMUNOMEDICS INCORPORATED | 252,574 | 1,634,000 | 1.38% | ||
| 49 | CARA THERAPEUTICS INC | 95,322 | 1,753,000 | 1.48% | ||
| 50 | CELLECTIS S A | 76,404 | 1,834,000 | 1.55% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001389933-17-000018, filed 2017.05.15).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
